161 related articles for article (PubMed ID: 34835192)
1. An Established Th2-Oriented Response to an Alum-Adjuvanted SARS-CoV-2 Subunit Vaccine Is Not Reversible by Sequential Immunization with Nucleic Acid-Adjuvanted Th1-Oriented Subunit Vaccines.
Cao H; Yang S; Wang Y; Luan N; Yin X; Lin K; Liu C
Vaccines (Basel); 2021 Nov; 9(11):. PubMed ID: 34835192
[TBL] [Abstract][Full Text] [Related]
2. Comparison of immune responses induced by two or three doses of an alum-adjuvanted inactivated SARS-CoV-2 vaccine in mice.
Luan N; Wang Y; Cao H; Lin K; Liu C
J Med Virol; 2022 May; 94(5):2250-2258. PubMed ID: 35112364
[TBL] [Abstract][Full Text] [Related]
3. Th2-Oriented Immune Serum After SARS-CoV-2 Vaccination Does Not Enhance Infection
Luan N; Li T; Wang Y; Cao H; Yin X; Lin K; Liu C
Front Immunol; 2022; 13():882856. PubMed ID: 35464483
[TBL] [Abstract][Full Text] [Related]
4. Protection from COVID-19 disease in hamsters vaccinated with subunit SARS-CoV-2 S1 mucosal vaccines adjuvanted with different adjuvants.
Sui Y; Andersen H; Li J; Hoang T; Bekele Y; Kar S; Lewis MG; Berzofsky JA
Front Immunol; 2023; 14():1154496. PubMed ID: 37020550
[TBL] [Abstract][Full Text] [Related]
5. Heterologous prime-boost vaccination with adenoviral vector and protein nanoparticles induces both Th1 and Th2 responses against Middle East respiratory syndrome coronavirus.
Jung SY; Kang KW; Lee EY; Seo DW; Kim HL; Kim H; Kwon T; Park HL; Kim H; Lee SM; Nam JH
Vaccine; 2018 Jun; 36(24):3468-3476. PubMed ID: 29739720
[TBL] [Abstract][Full Text] [Related]
6. Adjuvant-dependent effects on the safety and efficacy of inactivated SARS-CoV-2 vaccines during heterologous infection by a SARS-related coronavirus.
Heise M; Dillard J; Taft-Benz S; Knight A; Anderson E; Pressey K; Parotti B; Martinez S; Diaz J; Sarkar S; Madden E; De la Cruz G; Adams L; Dinnon K; Leist S; Martinez D; Schaefer A; Powers J; Yount B; Castillo I; Morales N; Burdick J; Evangelista MK; Ralph L; Pankow N; Linnertz C; Lakshmanane P; Montgomery S; Ferris M; Baric R; Baxter V
Res Sq; 2023 Oct; ():. PubMed ID: 37961507
[TBL] [Abstract][Full Text] [Related]
7. Effects of different adjuvants in the context of intramuscular and intranasal routes on humoral and cellular immune responses induced by detergent-split A/H3N2 influenza vaccines in mice.
Baz M; Samant M; Zekki H; Tribout-Jover P; Plante M; Lanteigne AM; Hamelin ME; Mallett C; Papadopoulou B; Boivin G
Clin Vaccine Immunol; 2012 Feb; 19(2):209-18. PubMed ID: 22190392
[TBL] [Abstract][Full Text] [Related]
8. Immunogenicity of Adjuvanted Psoralen-Inactivated SARS-CoV-2 Vaccines and SARS-CoV-2 Spike Protein DNA Vaccines in BALB/c Mice.
Sundaram AK; Ewing D; Liang Z; Jani V; Cheng Y; Sun P; Raviprakash K; Wu SJ; Petrovsky N; Defang G; Williams M; Porter KR
Pathogens; 2021 May; 10(5):. PubMed ID: 34069575
[TBL] [Abstract][Full Text] [Related]
9. Nanoadjuvants Produced by Advanced Nanochelating Technology in the Inactivated-Severe Acute Respiratory Syndrome Coronavirus-2 Vaccine Formulation: Preliminary Results on Cytokines and IgG Responses.
Kalanaky S; Fakharzadeh S; Karimi P; Hafizi M; Jamaati H; Hassanzadeh SM; Khorasani A; Mahdavi M; Nazaran MH
Viral Immunol; 2023; 36(6):409-423. PubMed ID: 37506342
[TBL] [Abstract][Full Text] [Related]
10. Prime-Pull Immunization of Mice with a BcfA-Adjuvanted Vaccine Elicits Sustained Mucosal Immunity That Prevents SARS-CoV-2 Infection and Pathology.
Shamseldin MM; Kenney A; Zani A; Evans JP; Zeng C; Read KA; Hall JM; Chaiwatpongsakorn S; Mahesh KC; Lu M; Eltobgy M; Denz P; Deora R; Li J; Peeples ME; Oestreich KJ; Liu SL; Corps KN; Yount JS; Dubey P
J Immunol; 2023 May; 210(9):1257-1271. PubMed ID: 36881867
[TBL] [Abstract][Full Text] [Related]
11. The immunogenicity of Alum+CpG adjuvant SARS-CoV-2 inactivated vaccine in mice.
Yang J; Li B; Yang D; Wu J; Yang A; Wang W; Lin F; Wan X; Li Y; Chen Z; Lv S; Pang D; Liao W; Meng S; Lu J; Guo J; Wang Z; Shen S
Vaccine; 2023 Sep; 41(41):6064-6071. PubMed ID: 37640568
[TBL] [Abstract][Full Text] [Related]
12. The Immunogenicity of CpG, MF59-like, and Alum Adjuvant Delta Strain Inactivated SARS-CoV-2 Vaccines in Mice.
Xu K; Li J; Lu X; Ge X; Wang K; Wang J; Qiao Z; Quan Y; Li C
Vaccines (Basel); 2024 Jan; 12(1):. PubMed ID: 38250873
[TBL] [Abstract][Full Text] [Related]
13. Improving the Th1 cellular efficacy of the lead Yersinia pestis rF1-V subunit vaccine using SA-4-1BBL as a novel adjuvant.
Dinc G; Pennington JM; Yolcu ES; Lawrenz MB; Shirwan H
Vaccine; 2014 Sep; 32(39):5035-40. PubMed ID: 25045812
[TBL] [Abstract][Full Text] [Related]
14. Th2 and Th17-associated immunopathology following SARS-CoV-2 breakthrough infection in Spike-vaccinated ACE2-humanized mice.
Zhang T; Magazine N; McGee MC; Carossino M; Veggiani G; Kousoulas KG; August A; Huang W
J Med Virol; 2024 Jan; 96(1):e29408. PubMed ID: 38258331
[TBL] [Abstract][Full Text] [Related]
15. Protection against SARS-CoV-2 infection by a mucosal vaccine in rhesus macaques.
Sui Y; Li J; Zhang R; Prabhu SK; Andersen H; Venzon D; Cook A; Brown R; Teow E; Velasco J; Greenhouse J; Putman-Taylor T; Campbell TA; Pessaint L; Moore IN; Lagenaur L; Talton J; Breed MW; Kramer J; Bock KW; Minai M; Nagata BM; Lewis MG; Wang LX; Berzofsky JA
JCI Insight; 2021 Apr; 6(10):. PubMed ID: 33908897
[TBL] [Abstract][Full Text] [Related]
16. Adjuvanting a subunit SARS-CoV-2 vaccine with clinically relevant adjuvants induces durable protection in mice.
Grigoryan L; Lee A; Walls AC; Lai L; Franco B; Arunachalam PS; Feng Y; Luo W; Vanderheiden A; Floyd K; Wrenn S; Pettie D; Miranda MC; Kepl E; Ravichandran R; Sydeman C; Brunette N; Murphy M; Fiala B; Carter L; Coffman RL; Novack D; Kleanthous H; O'Hagan DT; van der Most R; McLellan JS; Suthar M; Veesler D; King NP; Pulendran B
NPJ Vaccines; 2022 May; 7(1):55. PubMed ID: 35606518
[TBL] [Abstract][Full Text] [Related]
17. Boosting with heterologous vaccines effectively improves protective immune responses of the inactivated SARS-CoV-2 vaccine.
Zhang J; He Q; An C; Mao Q; Gao F; Bian L; Wu X; Wang Q; Liu P; Song L; Huo Y; Liu S; Yan X; Yang J; Cui B; Li C; Wang J; Liang Z; Xu M
Emerg Microbes Infect; 2021 Dec; 10(1):1598-1608. PubMed ID: 34278956
[TBL] [Abstract][Full Text] [Related]
18. Poly(I:C)/alum mixed adjuvant priming enhances HBV subunit vaccine-induced immunity in mice when combined with recombinant adenoviral-based HBV vaccine boosting.
Chuai X; Chen H; Wang W; Deng Y; Wen B; Ruan L; Tan W
PLoS One; 2013; 8(1):e54126. PubMed ID: 23335993
[TBL] [Abstract][Full Text] [Related]
19. Th2 and Th17-Associated Immunopathology Following SARS-CoV-2 Breakthrough Infection in Spike-Vaccinated ACE2-humanized Mice.
Zhang T; Magazine N; McGee MC; Carossino M; Veggiani G; Kousoulas KG; August A; Huang W
bioRxiv; 2023 Oct; ():. PubMed ID: 37904941
[TBL] [Abstract][Full Text] [Related]
20. An adjuvanted respiratory syncytial virus fusion protein induces protection in aged BALB/c mice.
Cherukuri A; Stokes KL; Patton K; Kuo H; Sakamoto K; Lambert S; Stillman E; Moore ML; Lee S
Immun Ageing; 2012 Oct; 9(1):21. PubMed ID: 23031690
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
